TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
LAB

Standard Biotools Inc

Healthcare · Medical Devices · —

0.722$ -5.4% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Standard Biotools Inc (LAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 627 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LAB
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
320 306 292 279 292 287 270 259 252 304 291 284 269 265 290 282 323 325 305 289 282 275 272 441 415 390 372 356 339 323 778 709 682 612 580 557 540 568 639 627
108 97 86 79 96 95 81 75 72 127 111 107 97 96 82 78 123 118 96 78 73 72 73 251 229 209 195 183 171 158 548 480 454 376 344 506 472 454 521 517
32 35 44 40 61 58 42 39 36 95 66 24 26 22 35 43 72 69 50 31 29 28 30 74 60 81 114 142 80 52 287 270 211 167 151 159 129 118 266 270
71 59 50 42 62 63 47 40 36 95 75 69 63 59 48 45 72 69 50 31 29 28 30 211 185 166 155 142 129 115 462 395 366 293 258 237 195 188 455 477
13 15 14 14 14 15 16 17 18 17 19 19 14 19 14 10.0 25 25 18 18 14 18 15 11 17 17 15 15 17 20 36 32 35 34 35 15 14 13 17 16
21 20 20 19 18 15 15 15 15 13 14 14 15 14 16 19 20 20 22 25 24 21 23 23 22 21 23 22 22 21 40 43 43 41 42 24 25 20 19 17
– – – – – – – – – – – – – – – – – – – 66 67 65 64 63 27 60 25 25 56 – – – 72 71 71 47 44 46 – –
104 104 104 104 104 104 104 104 104 104 104 104 104 104 106 106 106 107 106 106 106 106 106 106 106 106 106 106 106 106 106 106 106 111 112 – – – – –
83 80 77 74 71 69 66 63 60 57 55 52 49 46 51 48 45 42 39 36 32 28 26 19 16 13 10 7.2 4.3 1.4 25 24 23 29 28 – – – – –
252 253 254 255 253 256 221 224 230 232 109 111 107 111 149 150 171 186 182 180 183 181 250 479 478 472 469 469 471 160 200 198 192 141 125 132 140 143 78 87
28 30 31 34 32 33 34 37 39 38 34 37 33 33 35 38 43 54 54 53 47 50 47 43 46 43 44 47 52 109 122 124 121 66 56 98 108 108 42 57
– – – – – – – – – – 3.7 3.4 2.4 1.8 1.2 2.2 2.7 3.0 3.0 3.0 2.9 9.9 3.2 3.3 4.3 5.8 7.1 8.5 9.0 64 60 61 61 6.2 6.3 5.1 5.1 5.5 5.5 5.6
4.9 4.0 3.7 3.9 4.7 4.2 5.2 6.6 6.2 4.0 6.9 8.1 5.3 5.2 9.4 9.4 11 9.2 13 11 11 11 13 9.0 9.3 7.9 6.1 6.1 7.3 9.2 13 13 11 12 12 7.3 6.6 5.4 8.0 9.6
– – – – – – – – – – – – – – – – – – 54 54 64 64 100 65 64 63 62 61 60 4.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
68 53 39 24 39 31 49 35 22 72 182 173 163 154 141 133 152 139 123 109 99 95 22 -37 -63 -81 -97 -113 -132 163 577 510 489 472 455 425 400 424 561 540
-422 -439 -457 -474 -490 -500 -513 -529 -544 -559 -584 -598 -611 -624 -640 -653 -659 -677 -696 -713 -727 -736 -812 -876 -905 -926 -943 -960 -981 -1,001 -1,079 -1,125 -1,152 -1,186 -1,212 -1,245 -1,280 -1,261 -1,133 -1,160
29 29 29 29 35 39 39 39 39 41 58 69 69 70 70 71 72 74 75 75 76 77 77 78 79 79 79 79 79 80 294 372 372 375 378 380 383 385 388 391

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?